Sort
82,697 grants matching “vaccine development”
R5 SHIV/Macaque Models for the Evaluation of T and B Cell-Based HIV-1 Vaccines
$748,758Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R56 · FY2013 · AI
Human Plasma Cell Maturation & Maintenance through CD138, TNFRSF, and Modulation of Ig Secretion
$748,742Frances Eun-Hyung Lee · Emory University · R01 · FY2025 · AI
Effective CMV-based SIV vaccine regimens for newborn infants via IL-10 modulation
$748,719Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2022 · AI
Inhibiting poxvirus phosphatases: therapy and biodefense
$748,686Medical College Of Wisconsin · U01 · FY2003 · AI
Monoclonal Antibody Therapeutics for Candida auris
$748,593Arturo Casadevall · Johns Hopkins University · U19 · FY2025 · AI
Mimic Peptides of HIV-1 Epitopes as Vaccines
$748,571Mixture Sciences, Inc. · R44 · FY2005 · DA
Nanobind Hierarchical Silica Lamella for High Molecular Weight DNA Extraction
$748,562Kelvin Liu · Circulomics, Inc. · R44 · FY2016 · GM
Software for sequencing human antibody proteins from polyclonal immune responses
$748,548Anand Patel · Abterra Biosciences, Inc. · R44 · FY2022 · GM
Clinical analysis and therapeutic development of exosomal ACE2
$748,517Huiping Liu · Northwestern University At Chicago · R01 · FY2023 · AI
IP20-003, Data driven transmission models to optimize influenza vaccination and pandemic mitigation strategies - COVID-19 Supplement
$748,470Jonathan L Zelner · University Of Michigan At Ann Arbor · U01 · FY2022 · IP
A multidimensional Digital Approach to Address Vaccine Hesitancy and Increase COVID-19 Vaccine Uptake among African American Young Adults in the South
$748,462Lisa B Hightow-Weidman · Florida State University · R01 · FY2023 · MD
Imaging Viral Immunity
$748,434Jack R Bennink · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Liver resident memory for malaria
$748,391Sean C Murphy · University Of Washington · R01 · FY2019 · AI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross
$748,384Mark T Heise · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
$748,383Yonatan H Grad · Harvard School Of Public Health · R01 · FY2021 · AI
Impact of Fc N-glycan structure on HIV-specific antibody functions
$748,340Donald L. Jarvis · University Of Wyoming · R01 · FY2017 · AI
Restriction of HIV-1 transmission by type 1 interferons
$748,272Beatrice H Hahn · University Of Pennsylvania · R01 · FY2015 · AI
Partnership for Detection of Infection by Category B Pathogens
$748,258Frances S. Ligler · U.S. Naval Research Laboratory · U01 · FY2010 · AI
Developing broad-spectrum therapeutics against C. difficile toxins
$748,253Rongsheng Jin · University Of California-Irvine · R01 · FY2025 · AI
DNA Sequencing and Digital Gene Expression Core
$748,221Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Glycosylation Mutants of Leishmania
$748,199Stephen M Beverley · Washington University · R01 · FY2011 · AI
Understanding measles vaccine failure (and success) in Southern India
$748,182Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2020 · AI
Neutralizing and non-neutralizing antibody effector functions in HIV infected children
$748,130Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2019 · AI
Physiological and therapeutic effects of ANGPTL3 variants in mice and humans
$748,107Marina Cuchel · University Of Pennsylvania · R01 · FY2022 · HL
Cell entry, cross-species transmission and pathogenesis of novel coronavirus from
$748,081Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI